Home LiteratureArticle Details
PMID: 100331 Published · ppublish English Clinical Trial Controlled Clinical Trial Journal Article

Double-blind study of interferon administration in renal transplant recipients.

European journal of clinical investigation ·Vol. 8 ·No. 4 ·1978-08-00 ·Pages 255-8

Weimar W, Schellekens H, Lameijer LD, Masurel N, Edy VG, Billiau A, De Somer P

Abstract

In a double-blind trial renal allograft recipients were treated with fibroblast interferon preparations for 3 months in an attempt to prevent viral infections. Interferon therapy did not reduce the overall incidence of viral infections. No adverse effects were noted on liver function, platelet counts, or leucocyte counts, or acute rejection episodes.

MeSH Terms
Adolescent Adult Antibodies, Viral/analysis Clinical Trials as Topic Double-Blind Method Humans Interferons/therapeutic use Kidney Transplantation Middle Aged Transplantation, Homologous Virus Diseases/immunology,prevention & control
Chemicals
Antibodies, Viral Interferons
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Weimar W
Schellekens H
Lameijer L D
Masurel N
Edy V G
Billiau A
De Somer P
Article Info
Journal
European journal of clinical investigation
Abbr.
Eur J Clin Invest
ISSN
0014-2972
DOI
10.1111/j.1365-2362.1978.tb00861.x
Published
1978-08-00
Pages
255-8
Language
English
Region
England
NLM ID
0245331
Subset
IM
External Links
PubMed source DOI: 10.1111/j.1365-2362.1978.tb00861.x View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2